Fusion Antibodies PLC (FAB)

London
7.22
+0.50(+7.55%)
  • Volume:
    1,281,846
  • Bid/Ask:
    7.00/7.25
  • Day's Range:
    7.00 - 7.25

FAB Overview

Prev. Close
6.63
Day's Range
7-7.25
Revenue
1.86M
Open
6.63
52 wk Range
4.95-110
EPS
-0.067
Volume
1,281,846
Market Cap
2.06M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
637,425
P/E Ratio
-0.93
Beta
0.22
1-Year Change
-87.63%
Shares Outstanding
28,616,440
Next Earnings Date
20 Aug 2023
What is your sentiment on Fusion Antibodies?
or
Vote to see community's results!

Fusion Antibodies PLC Company Profile

Fusion Antibodies PLC Company Profile

Fusion Antibodies plc is a United Kingdom-based early discovery contract research organization located in Northern Ireland. The principal activity of the Company is the research, development and manufacture of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases. The Company offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. Its services include discovery, engineering, and supply. Discovery services include creation, screening and sequencing of novel monoclonal antibodies for therapeutic and diagnostic applications. Engineering services maximizing the performance of an antibody drug, including CDRx humanization, Antibody Developability by Design (ADDTM), RAMPTM, and OptiMASTM. Supply services include production of material for clinical production or further research, including transient expression and cGMP ready stable cell line development.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsBuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • placing soon?
    0
    • Why the rise today?
      0
      • huge spread , very off-putting
        1